• SELECT SITE CURRENCY
Select a currency for use throughout the site
Interferon Market Forecast to 2015
RNCOS E-Services Private Limited, June 2012, Pages: 37
One of the most effective clinical methods, used to treat a wide spectrum of diseases, protein-based therapies have found a prominent place in the biopharmaceutical industry. According to our new research report, the market for interferons (IFN), a family of glycoprotein cytokines which have antiviral, anti-proliferative, and immuno-modulatory properties, is expected to cross the US$ 10 Billion-mark by 2015. Increasing number of Hepatitis B and Hepatitis C cases across the globe will fuel growth in the market.
Our comprehensive report, “Interferon Market Forecast to 2015”, says that though the consumption of the interferon drugs is increasing, the segment is being hit by patent expirations. The study also looked into the shares of interferon beta and interferon alpha in the overall market. It also studied how the interferon market is performing in key geographies. It was found that Japan represents the largest market for interferon in Asia, and the third biggest in the world.
On studying the competitive landscape in the global interferon market, it was found that Biogen dominates the beta interferon market, followed by Merck. A brief overview of the activities of these key players has been included in the research work to depict a meaningful and clear picture of the market to clients.
1. Analyst View
2. Research Methodology
3. Global Protein Therapeutics Market
3.1 Protein Therapeutics Market Vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2015
3.2.1 Market Segmentation
4. Interferon Market Forecast to 2015
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2015
4.3 By Application
4.4 Key Geographical Markets
4.5 Key Players and Drugs
4.6 Recent Developments
5. Key Players
5.1 Roche Group
5.2 Biogen Idec Inc.
5.3 Merck Serono S.A.
List of Tables
Table 4-1: Global - Key Players and Drugs in Interferon Alpha Market (Million US$), 2011
Table 4-2: Global - Key Players and Drugs in Interferon Beta Market (Billion US$), 2011
Table 5-1: Roche - Key Products in Protein Therapeutics
Table 5-2: Biogen Idec - Key Products in Protein Therapeutics
Table 5-3: Merck Serono - Key Products in Protein Therapeutics
List of Charts
Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2011
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2011-2015
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2011
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2015
Figure 4-1: Global - Interferon Market (Billion US$), 2011-2015
Figure 4-2: Global - Share of Alpha and Beta Products in Interferon Market (2011)
Figure 4-3: Global - Interferon Alpha Market (Billion US$), 2009-2011
Figure 4-4: Global - Interferon Beta Market (Billion US$), 2009-2011
Figure 4-5: Global - Hepatitis B Market (Billion US$), 2011-2015
Figure 4-6: Global - Hepatitis C Market (Billion US$), 2011-2015
Figure 4-7: Global - Multiple Sclerosis Market (Billion US$), 2011-2015
Figure 4-8: US - Interferon Market (Billion US$), 2009 & 2010
Figure 4-9: Europe - Interferon Market (Million US$)
Figure 4-10: Japan - Interferon Market (Million US$), 2007-2010
- Roche Group
- Biogen Idec Inc.
- Merck Serono S.A.